DHS Further Analysis Reports No. 101
Health Economics Review, 2016 6:7 -Published: 11 February 2016
front cover © Hannah Maule-Ffinch/Save the Children
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non-MS. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically.
In this report a nutrition governance framework was applied to research and analyse the provincial experience with nutrition policy in Pakistan, looking both at chronic and acute malnutrition. Twenty-one in-depth interviews with key stakeholders were also conducted along with a review of published a...nd grey literature. Findings were validated and supplemented by consultative provincial roundtable meetings. Punjab’s nutritional puzzle is that it has high levels of chronic malnutrition and micro-nutrient deficiencies despite a surplus production of food and a low poverty level. Under-nutrition is mainly linked to insufficient attention to preventive health strategies and to a lack of connection between relevant sectors such as Education, Health, Poverty, Safe Water and Sanitation, and Food. Strategic opportunities are recommended which include cross-party political support and ownership for nutrition, with steering by executive leadership; multi-sectoral action and functional integration of various departments and programmes with the creation of a central convening structure for effective cross-sectoral coordination; broadening of nutritional activities beyond salt iodization and vitamin A coverage; central co-ordination of monitoring and evaluation and effective partnerships between the state and non-state sector around data production, awareness, advocacy, and monitoring.
more
L’expansion de la mise en œuvre des approches de suivi du traitement par la réalisation de tests de mesure de la charge virale et de tests de diagnostic chez le nourrisson sera indispensable pour garantir la qualité des soins et des traitements ainsi que le succès des programmes. Le fait de ch...oisir le réseau de diagnostic, les types d’échantillons ainsi que les interventions et les stratégies les plus appropriés dans chaque pays et pour chaque partenaire au niveau national et régional permettra de soutenir cet effort, de renforcer la collaboration et d’optimiser les investissements réalisés dans la mise en œuvre des tests en vue d’obtenir des effets manifestes.
more
Lancet Glob Health 2021; 9: e782–92
Este Manual pretende ser un documento de referencia para el desarrollo de Seguimiento Farmaco-
terapéutico a usuarios que se atiendan en centros de salud ambulatorios del país. Se entrega a los
Químicos Farmacéuticos locales una metodología estandarizada y probada en Chile como base para
el ...desarrollo de este servicio dirigido a usuarios con patologías crónicas, enfocado en la detección
y resolución de problemas de salud asociados al uso de medicamentos. Al mismo tiempo, entrega
herramientas para la implementación del servicio y su buen funcionamiento, junto con dar énfasis
en la importancia de la relación con el equipo de salud, buscando una mejor calidad de vida y cum-
plimiento de objetivos terapéuticos en los usuarios.
more
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
Cette évaluation avait pour buts d’examiner le Programme bilatéral intégré de santé familiale au
Bénin (IFHP) financé par l'USAID et de procéder à une évaluation des résultats obtenus à ce
jour à travers le Projet de réduction de la morbidité et de la mortalité causées par le pa...ludisme
(ARM3).
L
more
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages.
more